medigraphic.com
SPANISH

Salud Pública de México

Instituto Nacional de Salud Pública
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2025, Number 1

<< Back Next >>

salud publica mex 2025; 67 (1)

Internal migration seeking medical care for prostate cancer

Hernández-Pérez JG, Reyes-Morales H, Lajous M, Arenas P, Rodríguez-Covarrubias F, Manzanilla-García H, Mohar A,Torres-Sánchez L
Full text How to cite this article

Language: English
References: 25
Page: 39-47
PDF size: 1197.49 Kb.


Key words:

internal migration, medical care, Mexico, prostate cancer, spatial network analysis.

ABSTRACT

Objective. To characterize the migratory flow of Mexican men affiliated to Seguro Popular (SP) seeking medical care for prostate cancer (PC). Materials and methods. The administrative base for the treatment of incident CP (5 526 men) funded by the SP (2012-2016) was used. Oncological risk at diagnosis (low, intermediate, high) was estimated based on prostate-specific antigen, Gleason score, and clinical stage. Spatial network analysis and centrality measures were used to identify the health migratory flow. Results. 1 369 men sought treatment outside their state of residence, all of them with a diagnosis of PC (25%), mainly ‹65 years of age, highrisk PC, and residents of highly marginalized municipalities. Throughout the study period, Mexico City (closeness-in= 0.34) received the largest number of patients (importancein= 1 082) from 26 different states (degree-in= 26). This flow was more evident in patients with a high-risk PC, mainly towards hospitals with a high degree of specialization in cancer. Conclusions. A centralized migration (with two potential migration patterns) in search of treatment for PC was observed, mainly in men with high-risk PC.


REFERENCES

  1. Dos-Santos-Silva I, Gupta S, Orem J, Shulman LN. Global disparitiesin access to cancer care. Commun Med. 2022;2(1):31. https://doi.org/10.1038/s43856-022-00097-5

  2. Athanasakis K, Souliotis K, Kyriopoulos EJ, Loukidou E, Kritikou P, KyriopoulosJ. Inequalities in access to cancer treatment: an analysis of crossregionalpatient mobility in Greece. Supp Care Cancer. 2012;20(3):455-60.https://doi.org/10.1007/s00520-011-1093-0

  3. Berta P, Martini G, Spinelli D, Vittadini G. The beaten paths effect onpatient inter-regional mobility: an application to the Italian NHS. PapersReg Sci. 2022;101(4):945-7. https://doi.org/10.1111/pirs.12678

  4. Koylu C, Delil S, Guo D, Celik RN. Analysis of big patient mobility datafor identifying medical regions, spatio-temporal characteristics and caredemands of patients on the move. Int J Health Geogr. 2018;17(32). https://doi.org/10.1186/s12942-018-0152-x

  5. Messina G, Vigiani N, Lispi L, Nante N. Patient migration among theItalian regions in 2003. Italian J Public Health. 2008;5(1):45-52. https://doi.org/10.2427/5854

  6. Aggarwal A, Han L, Sullivan R, Haire K, Sangar V, van der Meulen J.Managing the cancer backlog: a national population-based study of patientmobility, waiting times and ‘spare capacity’ for cancer surgery. Lancet RegHealth. 2023;30:100642. https://doi.org/10.1016/j.lanepe.2023.100642

  7. Aggarwal A, Lewis D, Charman SC, Mason M, Clarke N, Sullivan R, et al.Determinants of patient mobility for prostate cancer surgery: a population-based study of choice and competition. Eur Urol. 2018;73(6):822-5.https://doi.org/10.1016/j.eururo.2017.07.013

  8. Wiese D, Lynch SM, Stroup AM, Maiti A, Harris G, Vucetic S, et al. Examiningsocio-spatial mobility patterns among colon cancer patients afterdiagnosis. SSM Popul Health. 2022;17:101023. https://doi.org/10.1016/j.ssmph.2022.101023

  9. LaPelusa M, Verduzco-Aguirre H, Diaz F, Aldaco F, Soto-Perez-de-Celis E.Cross-border utilization of cancer care by patients in the US and Mexico– a survey of Mexican oncologists. Global Health. 2023;19(1):78. https://doi.org/10.1186/s12992-023-00983-0

  10. Lightfoot N, Steggles S, Gauthier-Frohlick D, Arbour-Gagnon R,Conlon M, Innes C, et al. Psychological, physical, social, and economicimpact of travelling great distances for cancer treatment. Curr Oncol.2005;12(4):156-62. https://doi.org/10.3390/curroncol12040005

  11. Vetterlein MW, Löppenberg B, Karabon P, Dalela D, Jindal T, Sood A, etal. Impact of travel distance to the treatment facility on overall mortalityin US patients with prostate cancer. Cancer. 2017;123(17):3241-52. https://doi.org/10.1002/cncr.30744

  12. Turner M, Carriere R, Fielding S, Ramsay G, Samuel L, Maclaren A, et al.The impact of travel time to cancer treatment centre on post-diagnosiscare and mortality among cancer patients in Scotland. Health Place.2023;84:103139. https://doi.org/10.1016/j.healthplace.2023.103139

  13. Vindrola-Padros C, Brage E, Chambers P. On the road and away fromhome: a systematic review of the travel experiences of cancer patientsand their families. Supp Care Cancer. 2018;26(9):2973-82. https://doi.org/10.1007/s00520-018-4266-2

  14. Beltran-Ontiveros SA, Fernandez-Galindo MA, Moreno-Ortiz JM,Contreras-Gutierrez JA, Madueña-Molina J, Arambula-Meraz E, et al.Incidence, mortality, and trends of prostate cancer in Mexico from 2000to 2019: results from the Global Burden of Disease Study 2019. Cancers.2022;14(13):3184. https://doi.org/10.3390/cancers14133184

  15. Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, et al.Global Cancer Observatory: Cancer today (version 1.1). Lyon: InternationalAgency for Research on Cancer, 2024 [cited August 13, 202]. Availablefrom: https://gco.iarc.who.int/today

  16. Torres-Sánchez L, Hernández-Pérez JG, Escamilla-Nuñez C, Rodríguez-Covarrubias F, Manzanilla-García H, Mohar A, et al. Disparities on prostatecancer survival in Mexico: a retrospective cohort study. Salud Publica Mex.2023;65(3):236-44. https://doi.org/10.21149/14266

  17. González-Pier E, Barraza-Lloréns M, Gutiérrez-Delgado C, Vargas-Palacios A. Sistema de Protección Social en Salud. Elementos conceptuales,financieros y operativos. Mexico: FCE, Secretaría de Salud, FundaciónMexicana para la Salud, Instituto Nacional de Salud Pública, 2007.

  18. Graham J, Baker M, Macbeth F, Titshall V. Diagnosis and treatment ofprostate cancer: summary of NICE guidance. BMJ. 2008;336(7644):610-2.https://doi.org/10.1136/bmj.39498.525706.AD

  19. Consejo Nacional de Población. Índices de Marginación 2015. Mexico:Conapo, 2015 [cited April 9, 2023]. Available from: https://www.gob.mx/conapo/documentos/indice-de-marginacion- 2015-284579

  20. Csárdi G, Nepusz T, Müller K, Horvát S, Traag V, Zanini F, et al. igraph forR: R interface of the igraph library for graph theory and network analysis.Geneva: Zenodo, 2024 [cited April 9, 2023]. Available from: https://zenodo.org/records/10681749

  21. Hernández-Pérez JG, Reyes-Morales H, Lajous M, Arenas P, Rodríguez-Covarrubias F, Manzanilla-García H, et al. Supplemental material “Internalmigration of men affiliated to the public health insurance systemin Mexico seeking medical care for prostate cancer.” Mexico: figshare,2024 [cited August 15, 202]. Available from: https://figshare.com/articles/journal_contribution/_b_Supplemental_Material_Internal_Migration_seeking_medical_care_for_prostate_cancer_among_males_affiliated_to_Seguro_Popular_b_/26688559/3

  22. Cubero DIG, de Melo-Sette CV, de Camargo-Preto Piscopo B, deArruda-Monteiro CR, Maselli-Schoueri JH, de Andrade Tavares HD, et al.Epidemiological profile of Brazilian oncological patients seen by a referenceoncology center of the public health system and who migrate in search ofadequate health care. Rev Assoc Med Bras. 2018;64(9):814-8. https://doi.org/10.1590/1806-9282.64.09.814

  23. Balzano G, Guarneri G, Pecorelli N, Partelli S, Crippa S, Vico A, et al.Geographical disparities and patients’ mobility: a plea for regionalizationof pancreatic surgery in Italy. Cancers. 2023;15(9):2429. https://doi.org/10.3390/cancers15092429

  24. Consejo Nacional de Evaluación de la Política de Desarrollo Social.El Sistema de Protección Social en Salud: resultados y diagnóstico decierre. Mexico: Coneval, 2020 [cited July 31, 2023]. Available from: https://www.coneval.org.mx/EvaluacionDS/PP/CEIPP/IEPSM/Documents/analisis_spss_2020.pdf

  25. Glinos IA, Baeten R, Helble M, Maarse H. A typology of crossborderpatient mobility. Health Place. 2010;16(6):1145-55. https://doi.org/10.1016/j.healthplace.2010.08.001




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

salud publica mex. 2025;67